Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 2184-2187, 2006. First published October 26, 2006; 10.1373/clinchem.2006.069732
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.069732v1
52/12/2184    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rainey, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rainey, P. M.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2006;52:2184-2187.)
© 2006 American Association for Clinical Chemistry, Inc.


Point/Counterpoint

Automatic Reporting of Estimated Glomerular Filtration Rate—Jumping the Gun?

Petrie M. Rainey

Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA.

Address correspondence to this author at: Department of Laboratory Medicine, University of Washington School of Medicine, 1959 NE Pacific Street, Box 357110, Seattle, WA 98195. Fax 206-598-6189; e-mail: pmrainey@u.washington.edu.

The first 300 words of the full text of this article appear below.


   Introduction
 
In 2002, the Kidney Disease Outcomes Quality Initiative recommended the use of an estimated glomerular filtration rate (eGFR) to detect early kidney disease (1). Subsequently, the National Kidney Disease Education Program (NKDEP) has taken the lead in promoting the use of eGFR. In their recommendations to health professionals (2), the NKDEP suggested determining an eGFR, as well as measuring a spot urine albumin/creatinine ratio, in patients at high risk for kidney disease, i.e., those with diabetes, hypertension, or a family history of kidney disease. The NKDEP defines chronic kidney disease (CKD) as a GFR persistently <60 mL · min · 1.73 m–2 or albuminuria >30 mg/g creatinine. For calculating eGFR in adults, the NKDEP recommends using either of 2 versions of the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation.

In their Suggestions for Laboratories, the NKDEP "strongly encourages clinical laboratories to automatically report eGFR when serum creatinine is reported" (3). Beginning in late 2003, members of various kidney societies were asked to strongly encourage their local laboratories to report an eGFR with each creatinine result. Recently, this encouragement has extended to the proposal in several states of laws requiring the reporting of eGFR with every creatinine result (4). Laboratorians (and legislatures) should consider several reservations before adopting automatic reporting of eGFR.


   problems with Egfr as a general screening test
 
Most creatinine measurements are not made to assess renal function in persons who have CKD or are at high risk for CKD. The great majority of creatinine measurements are ordered as part of a Basic Metabolic Panel. The Basic Metabolic Panel is used for assessment and monitoring of hundreds of conditions, many unrelated to renal function. The most common indication in most hospital laboratories is for routine monitoring of inpatients. The recommendation to report an eGFR with . . . [Full Text of this Article]


   performance of Egfr in healthy populations
 

   lack of a confirmatory test
 

   absence of evidence
 

   recommendations
 

   Conclusions
 



The following articles in journals at HighWire Press have cited this article:


Home page
CJASNHome page
R. Botev and J.-P. Mallie
Reporting the eGFR and Its Implication for CKD Diagnosis
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1606 - 1607.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. A. Roberts, P. M. Srivastava, N. Macmillan, D. L. Hare, S. Ratnaike, K. Sikaris, and F. L. Ierino
B-type Natriuretic Peptides Strongly Predict Mortality in Patients Who Are Treated with Long-Term Dialysis
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1057 - 1065.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
P.D. Giles, P.B. Rylance, and D.C. Crothers
New results from the Modification of Diet in Renal Disease study: the importance of clinical outcomes in test strategies for early chronic kidney disease
QJM, February 1, 2008; 101(2): 155 - 158.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.